孫承溥 Cheng-Pu Sun Assistant Research Scientist
Office: BioTReC B548
Office TEL: (02)7750-5500#2564
E-mail: boom@gate.sinica.edu.tw
RESEARCH
Hepatitis B Virus (HBV)
Chronic hepatitis B remains a significant global public health burden, despite the implementation of widespread vaccination programs for over three decades. As of present, there are still approximately 240 million HBV carriers globally, including nearly 1.7 million in Taiwan. To prevent end-stage liver disease and death, many HBV patients require antiviral therapy. However, current treatments, such as interferon or nucleos(t)ide analogue, lack curative efficacy, necessitating the development of novel therapies. As the HBV virus cannot infect mice naturally, with the guidance of Dr. Mi-Hua Tao at Institute of Biomedical Sciences, we have developed several animal models, including HBV transgenic mice, humanized mice with a human liver system, and mice expressing HBV-like particles, all of which offer platforms for drug evaluation for academia and industry.
Adeno-associated Viral Vector (AAV) and Gene Therapy
I am also responsible for managing the Adeno-associated Virus (AAV) Core Facility led by Dr. Mi-Hua Tao at Institute of Biomedical Sciences. AAV vectors are rapid and effective research tools that offer insights into the physiological function of a gene or the potential of gene therapy. AAV vectors can express transgenes in mice for over a year, making them functionally similar to transgenic mice. The Academia Sinica AAV core facility not only helps researchers conduct basic research and publish their findings in top-tier international journals, but also assists the domestic physicians and industrial sectors in AAV drug development.
EDUCATION
Ph D. Molecular Medicine Program, Taiwan International Graduate Program
Institute of Biomedical Sciences, Academia Sinica
Institute of Biochemistry and Molecular Biology, National Yang-Ming University
M.S. Department of Microbiology, Microbiology and Immunology Division,
National Taiwan University
B.A. Department of Plant Pathology and Entomology, National Taiwan University
PROFESSIONAL EXPERIENCE
2023-present Assistant Research Scientist Biomedical Translation Research Center(BioTReC), Academia Sinica
2017-2022 Lab Manager Adeno-Associated Viral (AAV) Vector Core Facility, Academia Sinica
2013-2017 Post-doctoral Fellow Institute of Biomedical Sciences (IBMS), Academia Sinica
PUBLICATONS LIST
- Lee IJ, Lan YH, Wu PY, Wu YW, Chen YH, Tseng SC, Kuo TJ, Sun CP, Jan JT, Ma HH, Liao CC, Liang JJ, Ko HY, Chang CS, Liu WC, Ko YA, Chen YH, Sie ZL, Tsung SI, Lin YL, Wang IH, Tao MH. 2023. A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern. Emerg Microbes Infect 12:2149353.
- Huang HC, Wang SH, Fang GC, Chou WC, Liao CC, Sun CP, Jan JT, Ma HH, Ko HY, Ko YA, Chiang MT, Liang JJ, Kuo CT, Lee TA, Morales-Scheihing D, Shen CY, Chen SY, McCullough LD, Cui L, Wernig G, Tao MH, Lin YL, Chang YM, Wang SP, Lai YJ, Li CW. 2023. Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion. J Med Virol doi:10.1002/jmv.28478.
- Sung PS, Yang SP, Peng YC, Sun CP, Tao MH, Hsieh SL. 2022. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation. J Biomed Sci 29:52.
- Lee IJ*, Sun CP*, Wu PY, Lan YH, Wang IH, Liu WC, Yuan JP, Chang YW, Tseng SC, Tsung SI, Chou YC, Kumari M, Lin YS, Chen HF, Chen TY, Lin CC, Chiu CW, Hsieh CH, Chuang CY, Cheng CM, Lin HT, Chen WY, Hsu FF, Hong MH, Liao CC, Chang CS, Liang JJ, Ma HH, Chiang MT, Liao HN, Ko HY, Chen LY, Ko YA, Yu PY, Yang TJ, Chiang PC, Hsu ST, Lin YL, Lee CC, Wu HC, Tao MH. 2022. A booster dose of Delta x Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants. J Biomed Sci 29:49. (*Co-First Author)
- Wu CR, Kim HJ, Sun CP, Chung CY, Lin YY, Tao MH, Kim JH, Chen DS, Chen PJ. 2021. Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants. Hepatology doi:10.1002/hep.32307.
- Sun CP, Jan JT, Wang IH, Ma HH, Ko HY, Wu PY, Kuo TJ, Liao HN, Lan YH, Sie ZL, Chen YH, Ko YA, Liao CC, Chen LY, Lee IJ, Tsung SI, Lai YJ, Chiang MT, Liang JJ, Liu WC, Wang JR, Yuan JP, Lin YS, Tsai YC, Hsieh SL, Li CW, Wu HC, Ko TM, Lin YL, Tao MH. 2021. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19. PLoS Pathog 17:e1009758.
- Su SC, Yang TJ, Yu PY, Liang KH, Chen WY, Yang CW, Lin HT, Wang MJ, Lu RM, Tso HC, Chung MJ, Hsieh TY, Chang YL, Lin SC, Hsu FY, Ke FY, Wu YH, Hwang YC, Liu IJ, Liang JJ, Liao CC, Ko HY, Sun CP, Wu PY, Jan JT, Chang YC, Lin YL, Tao MH, Hsu SD, Wu HC. 2021. Structure-guided antibody cocktail for prevention and treatment of COVID-19. PLoS Pathog 17:e1009704.
- Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL. 2021. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge. Sci Rep 11:8761.
- Liang YJ, Teng W, Chen CL, Sun CP, Teng RD, Huang YH, Liang KH, Chen YW, Lin CC, Su CW, Tao MH, Wu JC. 2021. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development. Hepatology 74:641-655.
- Kulkarni R, Chen WC, Lee Y, Kao CF, Hu SL, Ma HH, Jan JT, Liao CC, Liang JJ, Ko HY, Sun CP, Lin YS, Wang YC, Wei SC, Lin YL, Ma C, Chao YC, Chou YC, Chang W. 2021. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS One 16:e0257191.
- Huang HC, Lai YJ, Liao CC, Yang WF, Huang KB, Lee IJ, Chou WC, Wang SH, Wang LH, Hsu JM, Sun CP, Kuo CT, Wang J, Hsiao TC, Yang PJ, Lee TA, Huang W, Li FA, Shen CY, Lin YL, Tao MH, Li CW. 2021. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine 74:103712.
- Liang YJ, Sun CP, Hsu YC, Chen YW, Wang IA, Su CW, Tao MH, Wu JC. 2020. Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion. J Biomed Sci 27:65.
- Huang TN, Hsu TT, Lin MH, Chuang HC, Hu HT, Sun CP, Tao MH, Lin JY, Hsueh YP. 2019. Interhemispheric Connectivity Potentiates the Basolateral Amygdalae and Regulates Social Interaction and Memory. Cell Rep 29:34-48 e4.
- Li TN, Wu YJ, Tsai HW, Sun CP, Wu YH, Wu HL, Pei YN, Lu KY, Yen TT, Chang CW, Chan HL, Tao MH, Liou JY, Chang MD, Su IJ, Wang LH. 2018. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis. J Pathol 245:502-513.
- Lai YH, Sun CP, Huang HC, Chen JC, Liu HK, Huang C. 2018. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice. BMC Complement Altern Med 18:248.
- Chang S, Bok P, Tsai CY, Sun CP, Liu H, Deussing JM, Huang GJ. 2018. NPTX2 is a key component in the regulation of anxiety. Neuropsychopharmacology 43:1943-1953.
- Zhang TY, Yuan Q, Zhao JH, Zhang YL, Yuan LZ, Lan Y, Lo YC, Sun CP, Wu CR, Zhang JF, Zhang Y, Cao JL, Guo XR, Liu X, Mo XB, Luo WX, Cheng T, Chen YX, Tao MH, Shih JW, Zhao QJ, Zhang J, Chen PJ, Yuan YA, Xia NS. 2016. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut 65:658-71.
- Chi HC, Chen SL, Tsai CY, Chuang WY, Huang YH, Tsai MM, Wu SM, Sun CP, Yeh CT, Lin KH. 2016. Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy. Autophagy doi:10.1080/15548627.2016.1230583:1-15.
- Chang S, Bok P, Sun CP, Edwards A, Huang GJ. 2016. Neuropsin Inactivation Has Protective Effects against Depressive-Like Behaviours and Memory Impairment Induced by Chronic Stress. PLoS Genet 12:e1006356.
- Shih YM*, Sun CP*, Chou HH, Wu TH, Chen CC, Wu PY, Enya Chen YC, Bissig KD, Tao MH. 2015. Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice. Sci Rep 5:15259. (*Co-First Author)
- Sun CP, Wu TH, Chen CC, Wu PY, Shih YM, Tsuneyama K, Tao MH. 2013. Studies of efficacy and liver toxicity related to adeno-associated virus-mediated RNA interference. Hum Gene Ther 24:739-50.
- Chen CC, Chang CM, Sun CP, Yu CP, Wu PY, Jeng KS, Hu CP, Chen PJ, Wu JC, Shih CH, Gershwin ME, Tao MH. 2012. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus. Gene Ther 19:25-33.
- Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, Sun CP, Tao MH, Tu PH, Chang C, Dickson DW, Chern Y. 2011. Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. J Cell Biol 194:209-27.
- Chen CC*, Sun CP*, Ma HI, Fang CC, Wu PY, Xiao X, Tao MH. 2009. Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol Ther 17:352-9. (*Co-First Author)
